Beijing Wantai’s HIV Urine Self-Test Kit Gains WHO Prequalification

Beijing Wantai's HIV Urine Self-Test Kit Gains WHO Prequalification

China-based Beijing Wantai Biological Pharmacy Enterprise Co., Ltd (SHA: 603392) announced that its HIV urine self-test kit—human immunodeficiency virus type 1 urine antibody test kit (colloidal gold method)—has obtained Prequalification (PQ) status from the World Health Organization (WHO) and has been included in the agency’s in vitro diagnostic (IVD) products list.

Product Overview
This product follows in the footsteps of Wantai Bio’s human immunodeficiency virus antibody diagnostic kit (enzyme-linked immunoassay) and human immunodeficiency virus (HIV 1+2) antibody detection kit (colloidal gold method), both of which have previously won WHO PQs. The HIV urine self-test kit is the world’s first of its kind to achieve this status, marking a significant milestone in the global fight against HIV/AIDS.-Fineline Info & Tech